Pershing Square Holdings, Ltd. Increases Position In Valeant Pharmaceuticals International

AMSTERDAM--(BUSINESS WIRE)-- Regulatory News:

Pershing Square Capital Management, L.P., the investment manager for Pershing Square Holdings, Ltd. (ticker: PSH:NA) has updated its Schedule 13D with the United States Securities and Exchange Commission, disclosing  that various funds it manages increased their beneficial ownership of Valeant Pharmaceuticals International, Inc. (ticker: NYSE: VRX), to 9.9% of shares outstanding.

About Pershing Square Holdings, Ltd.

Pershing Square Holdings, Ltd. (PSH:NA) is an investment holding company structured as a closed end fund that makes concentrated investments principally in North American companies.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151123006320/en/

MEDIA:
StockWell Communications
Tim Burt, +44 (0)20 7240 2486
[email protected]

Source: Pershing Square Capital Management, L.P.

You May Also Be Interested In

• TWO Announces Adjournment of Special Meeting
• Elmet Group to join Russell 3000 and Russell Microcap indexes
• Silexion gets German approval to begin Phase 2/3 pancreatic cancer trial